Traditional Chinese medicine composition for treating myasthenia gravis and preparation method thereof

Abstract

The invention relates to a traditional Chinese medicine composition for treating myasthenia gravis. The traditional Chinese medicine composition concretely comprises the following raw medicinal materials in parts by weight: 120-180 parts of astragalus membranaceus, 20-50 parts of radix pseudostellariae, 30-60 parts of codonopsis pilosula, 20-30 parts of bighead atractylodes rhizome, 6-10 parts of bupleurum chinense, 6-10 parts of rhizoma cimicifugae, 6-10 parts of angelica sinensis, 20-50 parts of Chinese yam, 6-10 parts of cortex albiziae, 15-40 parts of prepared fleece flower root, 6-20 parts of morinda officinalis, 6-20 parts of mulberry, 3-6 parts of liquorice, 3-6 parts of pericarpium citri reticulatae, 3-6 parts of fructus aurantii, 20-30 parts of caulis spatholobi, 10-20 parts of medlar and 5-12 parts of radix ophiopogonis. The traditional Chinese medicine composition can be used for strengthening the middle warmer and benefiting vital energy, strengthening the spleen and tonifying the kidneys, and soothing the liver and regulating qi as to a patient with myasthenia gravis, and clinical cure is achieved.

Description

technical field

[0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating myasthenia gravis and a preparation method thereof. Background technique

[0002] Myasthenia gravis (MG) is the main accumulation of acetylcholine receptor (AchR) on the postsynaptic membrane of neuromuscular junction (NMJ), mediated by acetylcholine receptor antibody (AchRAb), cellular immunity (cellular immunity CM ) dependent, complement-involved autoimmune diseases, the pathogenesis of which has not been fully clarified so far. The main clinical manifestation is skeletal muscle weakness. Previous studies believed that the pathogenesis of myasthenia gravis was related to humoral immunity mediated by acetylcholine receptor antibody (AchRAb), and now it is found that cytokines also play a very important role in the occurrence and development of myasthenia gravis, which participates in the production of AchRAb ...